ALAB Stock Cash Flow Statements

Astera Labs Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Astera Labs Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31

cash flows from operating activities
net income	51,219,000	31,819,000	24,713,000	-7,593,000	-7,546,000	-92,995,000
adjustments to reconcile net income to net cash from operating activities
stock-based compensation	35,474,000	42,446,000	48,218,000	45,535,000	43,067,000	97,768,000
depreciation and amortization	1,392,000	1,125,000
non-cash operating lease expense	826,000	696,000	741,000	581,000	584,000	522,000
warrants contra revenue	1,762,000	374,000	449,000	503,000	333,000	110,000
accretion of discounts on marketable securities	-1,947,000	-2,542,000		-3,231,000	-1,071,000	-566,000
other	1,759,000	-1,025,000
changes in operating assets and liabilities:
accounts receivable	45,459,000	-30,968,000	-13,426,000	-3,156,000	-5,476,000	-8,422,000
inventory	-7,790,000	-6,787,000	-18,016,000	4,699,000	-70,000	-5,900,000
prepaid expenses and other assets	-3,979,000	-14,495,000	-8,033,000	398,000	-2,730,000	-2,666,000
accounts payable	2,381,000	2,226,000	9,164,000	5,892,000	858,000	4,973,000
accrued expenses and other liabilities	10,084,000	-11,676,000	-76,000	20,164,000	706,000	10,224,000
operating lease liability	-1,274,000	-689,000	-749,000	-591,000	-624,000	-438,000
net cash from operating activities	135,366,000	10,504,000	39,703,000	63,508,000	29,813,000	3,652,000
capex	-2,023,000	-4,539,000	-15,448,000	-16,697,000	1,324,000	-3,424,000
free cash flows	133,343,000	5,965,000	24,255,000	46,811,000	31,137,000	228,000
cash flows from investing activities
purchases of property and equipment	-2,023,000	-4,539,000	-15,448,000	-16,697,000	1,324,000	-3,424,000
purchases of marketable securities	-213,861,000	-190,821,000	-205,654,000	-379,165,000	-322,448,000	-23,308,000
sales and maturities of marketable securities	152,191,000	191,420,000
net cash from investing activities	-63,693,000	-3,940,000	-91,427,000	-359,419,000	-302,471,000	-4,251,000
cash flows from financing activities
proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions			0	0	0	672,198,000
payment of deferred offering costs			0	0	-3,045,000	-1,756,000
tax withholding related to net share settlements of restricted stock units			0	0	0	-20,111,000
proceeds from exercises of stock options, net of repurchases	392,000	386,000				1,247,000
proceeds from employee stock purchase plan
net cash from financing activities	4,737,000	386,000	5,651,000	952,000	-2,343,000	651,578,000
net increase in cash, cash equivalents, and restricted cash	76,410,000	6,950,000
cash, cash equivalents, and restricted cash
beginning of the period	0	80,044,000		0	0	45,098,000
end of the period	76,410,000	86,994,000		-294,959,000	-275,001,000	696,077,000
supplemental disclosures of cash flow information:
conversion of redeemable convertible preferred stock into common stock in connection with initial public offering			0	0	0	255,127,000
purchases of property and equipment in accounts payable, accrued expenses and other current liabilities
right-of-use assets obtained in exchange for lease obligations				439,000	174,000	231,000
property and equipment acquired through tenant improvement allowance
deferred offering costs included in accounts payable and accrued expenses						3,045,000
depreciation			974,000	849,000	717,000	614,000
inventory write-downs			-783,000	-542,000
accretion of discounts on marketable securities and other
changes in operating assets and liabilities
other investing activities
proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
proceeds from exercises of stock options
repurchase of common stock upon termination
beginning of the year
end of the year
supplemental cash flow information:
exchange of common stock to series d redeemable convertible preferred stock
income taxes paid
maturities of marketable securities				15,803,000	11,411,000	9,365,000
sales of marketable securities				20,640,000	7,242,000	13,116,000
net increase in cash and cash equivalents				-294,959,000	-275,001,000	650,979,000
cash and cash equivalents
proceeds (payments) from exercises of stock options, net of repurchases
noncash investing and financing activities
purchases of property and equipment in accounts payable and accrued expenses
inventory write-down						428,000

We provide you with 20 years of cash flow statements for Astera Labs stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Astera Labs stock. Explore the full financial landscape of Astera Labs stock with our expertly curated income statements.

The information provided in this report about Astera Labs stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.